CLASS III ONGOING Drug recall · Reported 13 Nov 2024 · FDA Enforcement Report

Kids' Cough and Chest Congestion (Dextromethorphan HBr recalled

Denison Pharmaceuticals is recalling Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg). The recall was initiated on 25 Sep 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025
NDC69676-0079
UPC850015736018
Quantity recalled105,048 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0034-2025
FDA event ID
95430
Recalling firm
Denison Pharmaceuticals, Lincoln, RI
Manufacturer
Genexa Inc.
Classification
Class III
Status
Ongoing
Recall initiated
25 Sep 2024
FDA classified
1 Nov 2024
Reported
13 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Drug class
Pain Medication

Timeline

25 Sep 2024Recall initiated by company
1 Nov 2024Classified by FDA+37 days
13 Nov 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged in 4 oz bottles further packaged in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code# 850015736018

Where it was distributed

Product was distributed to two accounts that may have distributed the product further to the Retail Level.

Questions about this recall

Is Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg) recalled?

Yes. Denison Pharmaceuticals recalled Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg) on 25 Sep 2024. The recall is Class III and its status is Ongoing. Recall number D-0034-2025.

Why was it recalled?

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Which lots are affected?

Lot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025

Where was it sold?

Product was distributed to two accounts that may have distributed the product further to the Retail Level.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Denison Pharmaceuticals

All 8

Other Dextromethorphan Hbr, Guaifenesin, Acetaminophen, Doxylamine recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIAdult Cough and Chest Congestion recalled by Denison PharmaceuticalsMaximum Strength Cough And Chest Congestion And Nighttime Severe Cold And Flu Combo PackDenison PharmaceuticalsPackaging DefectsRI